Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin C for reducing chemotherapy adverse effects in nasopharyngeal cancer
TCTR20190316003Phase 3Completed
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nasopharyngeal carcinoma (NPC) comparing Intravenous vitamin C plus chemotherapy with Placebo plus chemotherapy (2 arms). Primary endpoint: Chemotherapy adverse effects. Started Mar 2019; status: completed.
02
Drugs
ascorbic acid
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on TCTR20190316003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190316003.